Guidewire Software Inc
For the period ended Jan 31, 2024. Filed Mar 8, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jan 31, 2024 · Filed Mar 8, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Condensed Consolidated Financial Statements
(unaudited)
- The Company and Summary of Significant Accounting Policies and Estimates
Company
Guidewire Software, Inc., a Delaware corporation, was incorporated on September 20, 2001. Guidewire Software, Inc., together with its subsidiaries (the “Company”), provides a technology platform and suite of products which combine core operations, digital engagement, analytics, and machine learning and artificial intelligence (“AI”) applications. The Company’s technology platform and suite of products support core insurance operations, including underwriting, policy administration, claim management, and billing; insights into data that can improve business decision making; and digital sales, service, and claims experiences for policyholders, agents, and other key stakeholders. The Company’s customers are primarily property and casualty insurance carriers. The term “products” generally refers to both subscription services and term license software offerings.
Basis of Presentation and Consolidation
The Company’s condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”). The condensed consolidated financial statements and notes include the Company and its wholly-owned subsidiaries and reflect all adjustments (all of which are normal and recurring in nature) that, in the opinion of management, are necessary for a fair presentation of the interim periods presented. All intercompany balances and transactions have been eliminated in consolidation. Certain information and disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted under the rules and regulations of the SEC.
These condensed consolidated financial statements should be read in conjunction with the Company’s financial statements and related notes, together with management’s discussion and analysis of financial condition and results of operations, presented in the Company’s Annual Report on Form 10-K for the fiscal year ended July 31, 2023.
Use of Estimates
In preparing the condensed consolidated financial statements and related disclosures in conformity with GAAP and pursuant to the rules and regulations of the SEC, the Company must make estimates and judgments that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results may differ materially from these estimates.
Significant Accounting Policies
There have been no changes in the Company’s significant accounting policies from those that were disclosed in the Company’s consolidated financial statements included in its Annual Report on Form 10-K for the fiscal year ended July 31, 2023, except for those disclosed herein.
Restricted Cash
Unearned acquisition consideration holdback subject to service conditions is held in escrow and considered restricted cash. At January 31, 2024, restricted cash in the amount of $1.2 million was included in prepaid expenses and other current assets in the condensed consolidated balance sheet.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash, cash equivalents, investments, accounts receivable, and unbilled accounts receivable. The Company maintains its cash, cash equivalents, and investments with high-quality financial institutions. The Company is exposed to credit risk for cash held in financial institutions in the event of a default to the extent that such amounts recorded in the condensed consolidated balance sheets are in excess of amounts that are insured by the Federal Deposit Insurance Corporation.
No customer accounted for 10% or more of the Company's revenue in the three and six months ended January 31, 2024 and 2023. No customer accounted for 10% or more of the Company's accounts receivable as of January 31, 2024 and July 31, 2023.
Recent Accounting Pronouncements
In November 2023, the Financial Accounting Standards Board (“FASB”) issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose information about their reportable segments’ significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280 on an interim and annual basis. The new standard will be effective and the Company will adopt it for the annual period beginning August 1, 2024, and for the interim periods beginning after August 1, 2025 with early adoption permitted. The Company is currently assessing the impact of adopting this standard on the consolidated financial statements.
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which improves the transparency of income tax disclosures by requiring consistent categories and greater disaggregation of information in the effective tax rate reconciliation and income taxes paid disaggregated by jurisdiction. It also includes certain other amendments to improve the effectiveness of income tax disclosures. The new standard will be effective and the Company will adopt it beginning August 1, 2025 and early adoption is permitted. Upon adoption, the guidance can be applied prospectively or retrospectively. The Company is currently assessing the impact of adopting this standard on the consolidated financial statements.
Other recent accounting pronouncements that will be applicable to the Company are not expected to have a material impact on its present or future financial statements.
- Revenue
Disaggregation of Revenue
Revenue by service or product type is as follows (in thousands):
| Three Months Ended · Six Months Ended | ||||
|---|---|---|---|---|
| January 31, | January 31, | |||
| 2024 | 2023 | 2024 | 2023 | |
| Subscription and support | ||||
| Subscription | $113,125 | $86,015 | $222,722 | $164,992 |
| Support | 18,517 | 19,739 | 36,547 | 39,830 |
| License | ||||
| Term license | 71,035 | 73,067 | 105,012 | 113,956 |
| Perpetual license | 48 | 48 | 96 | 111 |
| Services | 38,172 | 53,742 | 83,927 | 109,004 |
| Total revenue | $240,897 | $232,611 | $448,304 | $427,893 |
Revenue by service or product type and by geography is as follows (in thousands):
| Three Months Ended January 31, 2024 | ||||
|---|---|---|---|---|
| Subscription and support | License | Services | Total | |
| United States | $90,175 | $36,775 | $26,566 | $153,516 |
| Canada | 18,337 | 4,885 | 1,939 | 25,161 |
| Other Americas | 1,495 | 180 | 359 | 2,034 |
| Total Americas | 110,007 | 41,840 | 28,864 | 180,711 |
| Total EMEA | 14,027 | 17,590 | 7,087 | 38,704 |
| Total APAC | 7,608 | 11,653 | 2,221 | 21,482 |
| Total revenue | $131,642 | $71,083 | $38,172 | $240,897 |
| Three Months Ended January 31, 2023 | ||||
|---|---|---|---|---|
| Subscription and support | License | Services | Total | |
| United States | $71,344 | $39,421 | $36,300 | $147,065 |
| Canada | 17,536 | 5,912 | 4,425 | 27,873 |
| Other Americas | 1,481 | 532 | 683 | 2,696 |
| Total Americas | 90,361 | 45,865 | 41,408 | 177,634 |
| Total EMEA | 9,712 | 15,708 | 10,264 | 35,684 |
| Total APAC | 5,681 | 11,542 | 2,070 | 19,293 |
| Total revenue | $105,754 | $73,115 | $53,742 | $232,611 |
| Six Months Ended January 31, 2024 | ||||
|---|---|---|---|---|
| Subscription and support | License | Services | Total | |
| United States | $176,926 | $49,506 | $57,567 | $283,999 |
| Canada | 36,779 | 7,803 | 4,133 | 48,715 |
| Other Americas | 2,985 | 502 | 921 | 4,408 |
| Total Americas | 216,690 | 57,811 | 62,621 | 337,122 |
| Total EMEA | 27,965 | 26,955 | 16,701 | 71,621 |
| Total APAC | 14,614 | 20,342 | 4,605 | 39,561 |
| Total revenue | $259,269 | $105,108 | $83,927 | $448,304 |
| Six Months Ended January 31, 2023 | ||||
|---|---|---|---|---|
| Subscription and support | License | Services | Total | |
| United States | $138,425 | $56,930 | $74,825 | $270,180 |
| Canada | 33,587 | 9,605 | 10,477 | 53,669 |
| Other Americas | 2,956 | 852 | 1,105 | 4,913 |
| Total Americas | 174,968 | 67,387 | 86,407 | 328,762 |
| Total EMEA | 18,640 | 26,133 | 18,158 | 62,931 |
| Total APAC | 11,214 | 20,547 | 4,439 | 36,200 |
| Total revenue | $204,822 | $114,067 | $109,004 | $427,893 |
No country or region, other than those presented above, accounted for more than 10% of total revenue during the three and six months ended January 31, 2024 and 2023.
Customer Contract– Related Balance Sheet Amounts
Amounts related to customer contract-related arrangements are included on the condensed consolidated balance sheets as follows (in thousands):
| January 31, 2024 | July 31, 2023 | |
|---|---|---|
| Unbilled accounts receivable, net | $97,762 | $98,864 |
| Contract costs, net | $46,512 | $47,254 |
| Deferred revenue, net | $199,155 | $212,911 |
As of January 31, 2024 and July 31, 2023, there wasno allowance for credit losses associated with unbilled accounts receivable.
Contract costs
The current portion of contract costs of $15.8 million and $15.9 million is included in prepaid and other current assets in the Company’s condensed consolidated balance sheets as of January 31, 2024 and July 31, 2023, respectively. The non-current portion of contract costs of $30.7 million and $31.3 million is included in other assets in the Company’s condensed consolidated balance sheets as of January 31, 2024 and July 31, 2023, respectively. The Company amortized $4.7 million and $4.1 million of contract costs during the three months ended January 31, 2024 and 2023, respectively, and amortized $8.7 million and $8.6 million during the six months ended January 31, 2024 and 2023, respectively.
Deferred revenue
During the three and six months ended January 31, 2024, the Company recognized revenue of approximately $56.9 million and $151.8 million, respectively, related to the Company’s deferred revenue balance reported as of July 31, 2023.
Remaining Performance Obligations
The aggregate amount of consideration allocated to remaining performance obligations either not satisfied or partially satisfied was approximately $1.5 billion as of January 31, 2024. Subscription services are typically satisfied over three to five years, support services are generally satisfied within one year, and professional services are typically satisfied within one year. Professional services under time and material contracts are not included in the remaining performance obligations calculation as these arrangements can be cancelled at any time.
- Fair Value of Financial Instruments
Available-for-sale investments within cash equivalents and investments consist of the following (in thousands):
| January 31, 2024 | ||||
|---|---|---|---|---|
| Amortized Cost | Unrealized Gains | Unrealized Losses | Estimated Fair Value | |
| Asset-backed securities | $41,461 | $105 | $(89) | $41,477 |
| Certificates of deposit | 54,059 | — | — | 54,059 |
| Commercial paper | 162,569 | — | — | 162,569 |
| Corporate bonds | 249,799 | 794 | (304) | 250,289 |
| Foreign government bonds | 8,353 | 32 | (68) | 8,317 |
| Money market funds | 188,952 | — | — | 188,952 |
| U.S. Government agency securities | 30,675 | 14 | (20) | 30,669 |
| U.S. Government bonds | 86,142 | 88 | (531) | 85,699 |
| Total | $822,010 | $1,033 | $(1,012) | $822,031 |
| July 31, 2023 | ||||
|---|---|---|---|---|
| Amortized Cost | Unrealized Gains | Unrealized Losses | Estimated Fair Value | |
| Asset-backed securities | $43,573 | $18 | $(234) | $43,357 |
| Certificates of deposit | 34,395 | — | — | 34,395 |
| Commercial paper | 150,254 | — | — | 150,254 |
| Corporate bonds | 200,691 | 41 | (1,590) | 199,142 |
| Foreign government bonds | 14,559 | — | (203) | 14,356 |
| Money market funds | 229,721 | — | — | 229,721 |
| U.S. Government agency securities | 84,180 | 9 | (151) | 84,038 |
| U.S. Government bonds | 87,064 | 1 | (1,230) | 85,835 |
| Total | $844,437 | $69 | $(3,408) | $841,098 |
The Company does not consider any portion of the unrealized losses at January 31, 2024 to be credit losses. The Company has recorded the securities at fair value in its condensed consolidated balance sheets, with unrealized gains and losses reported as a component of accumulated other comprehensive income (loss). The amount of unrealized gains and losses reclassified into earnings is based on the specific identification of the securities sold. The realized gains and losses from sales of securities are presented in the condensed consolidated statements of comprehensive income (loss).
The following table summarizes the contractual maturities of the Company’s available-for-sale investments measured at fair value (in thousands):
| January 31, 2024 | |||
|---|---|---|---|
| Less Than 12 Months | 12 Months or Greater | Total | |
| Asset-backed securities | $627 | $40,850 | $41,477 |
| Certificates of deposit | 54,059 | — | 54,059 |
| Commercial paper | 162,569 | — | 162,569 |
| Corporate bonds | 167,481 | 82,808 | 250,289 |
| Foreign government bonds | 4,868 | 3,449 | 8,317 |
| Money market funds | 188,952 | — | 188,952 |
| U.S. Government agency securities | 27,831 | 2,838 | 30,669 |
| U.S. Government bonds | 60,583 | 25,116 | 85,699 |
| Total | $666,970 | $155,061 | $822,031 |
Fair Value Measurement
Available-for-sale investments
The following tables summarize the Company’s available-for-sale investments measured at fair value, by level within the fair value hierarchy (in thousands):
| January 31, 2024 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Cash equivalents: | ||||
| Commercial paper | $— | $50,384 | $— | $50,384 |
| Money market funds | 188,952 | — | — | 188,952 |
| Total cash equivalents | 188,952 | 50,384 | — | 239,336 |
| Short-term investments: | ||||
| Asset-backed securities | — | 627 | — | 627 |
| Certificates of deposit | — | 54,059 | — | 54,059 |
| Commercial paper | — | 112,185 | — | 112,185 |
| Corporate bonds | — | 167,481 | — | 167,481 |
| Foreign government bonds | — | 4,868 | — | 4,868 |
| U.S. Government agency securities | — | 27,831 | — | 27,831 |
| U.S. Government bonds | — | 60,583 | — | 60,583 |
| Total short-term investments | — | 427,634 | — | 427,634 |
| Long-term investments: | ||||
| Asset-backed securities | — | 40,850 | — | 40,850 |
| Corporate bonds | — | 82,808 | — | 82,808 |
| Foreign government bonds | — | 3,449 | — | 3,449 |
| U.S. Government agency securities | — | 2,838 | — | 2,838 |
| U.S. Government bonds | — | 25,116 | — | 25,116 |
| Total long-term investments | — | 155,061 | — | 155,061 |
| Total | $188,952 | $633,079 | $— | $822,031 |
| July 31, 2023 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Cash equivalents: | ||||
| Commercial paper | $— | $61,296 | $— | $61,296 |
| Money market funds | 229,721 | — | — | 229,721 |
| U.S. Government agency securities | — | 8,478 | — | 8,478 |
| U.S. Government bonds | — | 15,949 | — | 15,949 |
| Total cash equivalents | 229,721 | 85,723 | — | 315,444 |
| Short-term investments: | ||||
| Asset-backed securities | — | 2,705 | — | 2,705 |
| Certificates of deposit | — | 34,395 | — | 34,395 |
| Commercial paper | — | 88,958 | — | 88,958 |
| Corporate bonds | — | 156,396 | — | 156,396 |
| Foreign government bonds | — | 10,717 | — | 10,717 |
| U.S. Government agency securities | — | 69,101 | — | 69,101 |
| U.S. Government bonds | — | 34,600 | — | 34,600 |
| Total short-term investments | — | 396,872 | — | 396,872 |
| Long-term investments: | ||||
| Asset-backed securities | — | 40,652 | — | 40,652 |
| Corporate bonds | — | 42,746 | — | 42,746 |
| Foreign government bonds | — | 3,639 | — | 3,639 |
| U.S. Government agency securities | — | 6,459 | — | 6,459 |
| U.S. Government bonds | — | 35,286 | — | 35,286 |
| Total long-term investments | — | 128,782 | — | 128,782 |
| Total | $229,721 | $611,377 | $— | $841,098 |
Convertible Senior Notes
In March 2018, the Company issued $400.0 million aggregate principal amount of 1.25% Convertible Senior Notes due 2025 (the “Convertible Senior Notes”). The fair value of the Convertible Senior Notes was $444.0 million and $388.2 million at January 31, 2024 and July 31, 2023, respectively. The Company estimates the fair value of the Convertible Senior Notes using commonly accepted valuation methodologies and market-based risk measurements that are directly observable, such as unadjusted quoted prices in markets that are not active (Level 2).
Strategic Investments
The Company’s other assets include strategic investments in privately-held companies in which the Company does not have a controlling interest or the ability to exert significant influence. The strategic investments consist of non-marketable equity securities that do not have readily determinable market values (Level 3), which are recorded using the measurement alternative at cost less impairment and adjusts cost for subsequent observable changes in fair value, and an investment in a limited partnership, which is recorded using the net asset value practical expedient (Level 3) in accordance with ASC 820. Changes in fair value are recorded in other income (expense) on the condensed consolidated statements of operations.
During the six months ended January 31, 2024, the Company invested $0.2 million in a new strategic investment.
During the six months ended January 31, 2024, one of the Company’s investees was acquired by a privately-held limited partnership. As a result, the Company received $12.1 million in consideration for its equity interest in the investee, composed of $6.5 million cash and $5.6 million of an ownership interest in the privately-held limited partnership, and recognized a $1.8 million gain in excess of cost in other income (expense), net on the condensed consolidated statements of operations.
The following table summarizes the carrying amount of the Company’s strategic investments (in thousands):
| January 31, 2024 | July 31, 2023 | |
|---|---|---|
| Equity investments using the measurement alternative | $17,654 | $27,772 |
| Equity investment using net asset value | $5,618 | $— |
No impairment charge or unrealized gain or loss related to strategic investments were recognized during the three and six months ended January 31, 2024 and 2023.
- Net Income (Loss) Per Share
The Company calculates basic earnings per share by dividing the net income (loss) by the weighted average number of shares of common stock outstanding for the period. For calculating diluted earnings per share, the Company uses the treasury stock method for options to purchase common stock and Stock Awards and the if-converted method for Convertible Senior Notes.
The following table sets forth the computation of the Company’s basic and diluted net income (loss) per share for the three and six months ended January 31, 2024 and 2023 (in thousands, except share and per share amounts):
| Three Months Ended · Six Months Ended | ||||
|---|---|---|---|---|
| January 31, | January 31, | |||
| 2024 | 2023 | 2024 | 2023 | |
| Numerator: | ||||
| Net income (loss) | $9,687 | $(9,189) | $(17,384) | $(78,507) |
| Net income (loss) per share: | ||||
| Basic | $0.12 | $(0.11) | $(0.21) | $(0.95) |
| Diluted | $0.12 | $(0.11) | $(0.21) | $(0.95) |
| Denominator: | ||||
| Weighted average shares used in computing net income (loss) per share: | ||||
| Basic | 82,133,632 | 82,051,867 | 81,912,272 | 82,686,420 |
| Weighted average effect of dilutive stock options | 50,171 | — | — | — |
| Weighted average effect of dilutive stock awards | 1,121,277 | — | — | — |
| Diluted | 83,305,080 | 82,051,867 | 81,912,272 | 82,686,420 |
The following weighted average shares of potential common stock were excluded from the computation of diluted net income (loss) per share for the periods presented because including them would have been anti-dilutive:
| Three Months Ended · Six Months Ended | ||||
|---|---|---|---|---|
| January 31, | January 31, | |||
| 2024 | 2023 | 2024 | 2023 | |
| Stock options | — | 14,686 | 184,669 | 14,746 |
| Stock awards | 502,562 | 1,960,572 | 3,299,881 | 1,664,469 |
| Convertible senior notes | 3,516,480 | 3,516,480 | 3,516,480 | 3,516,480 |
During the three and six months ended January 31, 2024 and 2023, the average market price of the Company’s common stock did not exceed the initial conversion price of the Convertible Senior Notes.
- Commitments and Contingencies
There has been no material change in the Company’s contractual obligations and commitments other than in the ordinary course of business since the Company’s fiscal year ended July 31, 2023.
See the Company’s Annual Report on Form 10-K for the fiscal year ended July 31, 2023 for additional information regarding the Company’s contractual obligations.
Legal Proceedings
From time to time, the Company is involved in various legal proceedings and receives claims, arising from the normal course of business activities. The Company has not recorded any accrual for claims as of January 31, 2024 or July 31, 2023. The Company has not accrued for estimated losses in the accompanying condensed consolidated financial statements as the Company has determined that no provision for liability nor disclosure is required related to any claim against the Company because: (a) there is not a reasonable possibility that a loss exceeding amounts already recognized (if any) may be incurred with respect to such claim; (b) a reasonably possible loss or range of loss cannot be estimated; or (c) such estimate is immaterial. The Company expenses legal fees in the period in which they are incurred.
Indemnification
The Company sells software licenses and services to its customers under Software License Agreements (“SLA”) and Software Subscription Agreements (“SSA”). SLAs and SSAs contain the terms of the contractual arrangement with the customer and generally include certain provisions for defending the customer against any claims that the Company’s software infringes upon a patent, copyright, trademark, or other proprietary right of a third party, and in the case of SSAs, the Company may include certain provisions for limited liability for defending the customer against any claims for a data breach. SLAs and SSAs also generally indemnify the customer against judgments, settlements, fines, penalties, costs, and expenses resulting from a claim (“Losses”) against the customer in the event the Company’s software is found to infringe upon such third-party rights.
The Company hasnot had to reimburse any of its customers for Losses related to indemnification provisions andno material claims against the Company were outstanding as of January 31, 2024 or July 31, 2023. For several reasons, including the lack of prior indemnification claims and the lack of a monetary liability limit for certain infringement cases under various SLAs and SSAs, the Company cannot estimate the amount of potential future payments, if any, related to indemnification provisions.
The Company has also agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines, and settlement amounts incurred by any of these persons in any action or proceeding to which any of these persons is, or is threatened to be, made a party by reason of the person’s service as a director or officer, including any action by the Company, arising out of that person’s services as the Company’s director or officer or that person’s services provided to any other company or enterprise at the Company’s request. The Company maintains director and officer insurance coverage that may enable the Company to recover a portion of any future amounts paid.
- Stock-Based Compensation Expense and Shareholders’ Equity
Stock-Based Compensation Expense
Stock-based compensation expense related to stock options and Stock Awards is included in the Company’s condensed consolidated statements of operations as follows (in thousands):
| Three Months Ended · Six Months Ended | ||||
|---|---|---|---|---|
| January 31, | January 31, | |||
| 2024 | 2023 | 2024 | 2023 | |
| Stock-based compensation expense | $36,403 | $36,296 | $72,602 | $71,545 |
| Net impact of deferred stock-based compensation | 24 | (117) | (78) | (270) |
| Total stock-based compensation expense, net | $36,427 | $36,179 | $72,524 | $71,275 |
| Stock-based compensation expense is included in the following categories: | ||||
| Cost of subscription and support revenue | $3,414 | $3,440 | $6,876 | $6,908 |
| Cost of license revenue | 53 | 119 | 148 | 266 |
| Cost of services revenue | 4,643 | 4,397 | 9,432 | 9,746 |
| Research and development | 10,138 | 10,301 | 20,124 | 19,592 |
| Sales and marketing | 8,190 | 8,024 | 15,919 | 14,911 |
| General and administrative | 9,989 | 9,898 | 20,025 | 19,852 |
| Total stock-based compensation expense | $36,427 | $36,179 | $72,524 | $71,275 |
Total unrecognized stock-based compensation expense related to the Company’s stock options and Stock Awards as of January 31, 2024 is as follows:
| Unrecognized Expense(in thousands) | Weighted Average Expected Recognition Period (in years) | |
|---|---|---|
| Stock Options | $1,298 | 0.6 |
| Stock Awards | 310,253 | 2.6 |
| Total unrecognized stock-based compensation expense | $311,551 |
Stock Awards
A summary of Stock Awards activity under the Company’s equity incentive plans is as follows:
| Stock Awards Outstanding | |||
|---|---|---|---|
| Number of Stock Awards Outstanding | Weighted Average Grant Date Fair Value | Aggregate Intrinsic Value (in thousands)(1) | |
| Balance as of July 31, 2023 | 3,414,706 | $85.68 | $289,635 |
| Granted | 1,559,426 | $92.18 | |
| Released | (881,072) | $91.73 | $82,848 |
| Canceled | (156,813) | $89.10 | |
| Balance as of January 31, 2024 | 3,936,247 | $86.76 | $439,600 |
| Expected to vest as of January 31, 2024 | 3,936,247 | $86.76 | $439,600 |
(1)Aggregate intrinsic value at each period end represents the total market value of Stock Awards at the Company’s closing stock price of $111.68 and $84.82 on January 31, 2024 and July 31, 2023, respectively. Aggregate intrinsic value for released Stock Awards represents the total market value of released Stock Awards at date of release.
In September 2023, certain executive officers were granted Stock Awards that vest in September 2026, subject to continued service until such time, with the opportunity to increase the number of vested awards based on Company financial performance and, for a select number of awards, the market performance of the Company’s common stock. The fair value of the awards will be recognized over the performance period and may increase or decrease depending on the estimated attainment of Company financial performance criteria. The Company determined the fair value of the portion of the award subject to the market performance of the Company’s common stock using a Monte Carlo simulation model, which included the following assumptions:
| Performance Period | September 13, 2023 to September 13, 2026 |
|---|---|
| 3-year Historical Volatility | 35.0% |
| 3-year Risk Free Rate | 4.5% |
For the portion of the award subject to the market performance of the Company’s common stock, stock-based compensation expense is recognized over the requisite service period regardless of whether or not the market condition is ultimately satisfied, subject to continued service over the period.
Prior to fiscal year 2024, certain executives and employees of the Company received PSUs, which will vest over three years with 50% vesting annually over the three year period and the remaining 50% vesting at the end of the third year.
The Company recognized stock-based compensation related to PSUs of $3.0 million and $3.2 million during the three months ended January 31, 2024 and 2023, respectively, and $7.1 million and $7.2 million during the six months ended January 31, 2024 and 2023, respectively.
Stock Options
A summary of stock option activity under the Company’s equity incentive plans is as follows:
| Stock Options Outstanding | ||||
|---|---|---|---|---|
| Number of Stock Options Outstanding | Weighted Average Exercise Price | Weighted Average Remaining Contractual Life | Aggregate Intrinsic Value(1) | |
| (in years) · (in thousands) | ||||
| Balance as of July 31, 2023 | 187,572 | $65.90 | 8.8 | $3,549 |
| Granted | — | $— | ||
| Exercised | (369) | $14.82 | $34 | |
| Canceled | (5,217) | $68.39 | ||
| Balance as of January 31, 2024 | 181,986 | $65.93 | 8.3 | $8,326 |
| Vested and expected to vest as of January 31, 2024 | 181,986 | $65.93 | 8.3 | $8,326 |
| Exercisable as of January 31, 2024 | 7,855 | $11.49 | 2.7 | $787 |
(1)Aggregate intrinsic value at each period end represents the difference between the Company’s closing stock price of $111.68 and $84.82 on January 31, 2024 and July 31, 2023, respectively, and the exercise price of outstanding options. Aggregate intrinsic value for exercised options represents the difference between the Company’s stock price at date of exercise and the exercise price.
Share Repurchase Program
In September 2022, the Company's board of directors authorized and approved a share repurchase program of up to $400.0 million of the Company's outstanding common stock. Share repurchases under the program may be made from time to time, in the open market, in privately negotiated transactions and otherwise, at the discretion of management of the Company and in accordance with applicable federal securities laws, including Rule 10b-18 of the Exchange Act, and other applicable legal requirements. Such repurchases may also be made in compliance with Rule 10b5-1 trading plans entered into by the Company.
During the three and six months ended January 31, 2024, the Company did not repurchase any shares of common stock. During the three months ended January 31, 2023, the Company did not repurchase any shares of common stock. During the six months ended January 31, 2023, the Company repurchased 2,581,478 shares of common stock.
As of January 31, 2024, $138.2 million remained available for future share repurchases.
In the first quarter of fiscal year 2023, the Company entered into an accelerated share repurchase (“ASR”) agreement with a large financial institution whereupon the Company provided them with a prepayment of $200.0 million and received an initial delivery of 2,581,478 shares of the Company’s common stock. In the third quarter of fiscal year 2023, the ASR was settled in full with the delivery of an additional 648,001 shares of common stock which resulted in total repurchases under the ASR of 3,229,479 shares of common stock at an average purchase price of $61.93 per share.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.